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Abstract Recent analyses suggest the decline in coronary
heart disease mortality rates is slowing in younger age
groups in countries such as the US and the UK. This work
aimed to analyse recent trends in cardiovascular mortality
rates in the Netherlands. Analysis was of annual all cir-
culatory, ischaemic heart disease (IHD), and cerebrovas-
cular disease mortality rates between 1980 and 2009 for the
Netherlands. Data were stratified by sex and 10-year age
group (age 35–85?). The annual rate of change and sig-
nificant changes in the trend were identified using joinpoint
Poisson regression. For almost all age and sex groups
examined the rate of IHD and cerebrovascular disease
mortality in the Netherlands has more than halved between
1980 and 2009. The decline in mortality from both IHD
and cerebrovascular disease is continuing for all ages and
sex groups, with anacceleration in the decline apparent
from the late 1990s/early 2000s. The decline in age-specific
all circulatory, coronary heart disease and cerebrovascular
disease mortality rates continues for all age and sex groups
in the Netherlands.
Keywords Mortality rate  Netherlands  Trends 
Cardiovascular disease  Coronary heart disease
The decline in age-standardised cardiovascular disease
(CVD) mortality rates has continued since the 1960s in the
developed world [1]. In the USA, rates declined from
around 830/100,000 population in 1960 to around
380/100,000 population in 1997 [1]. There appeared to be a
slowing of the decline in age-standardised cardiovascular
and coronary heart disease mortality rates in the USA
between 1990 and 1997. However, more recent publica-
tions suggest the decline in age-standardised coronary heart
disease (CHD) mortality rates has continued since 1997 in
countries such as the USA, UK and Australia, and has in
fact accelerated in recent years [2, 3].
In the past 2 years there have been reports of a slowing
of the decline in CHD mortality rates at younger ages in
developed countries [2–4]. Detailed reports from the UK
and USA, have both demonstrated that in those aged under
55 years, CHD mortality rates have stopped decreasing,
and even increased, for the first time in over two decades.
To date there have been no analyses of trends in coro-
nary heart disease mortality rates at younger ages in
non-Anglo Saxon countries. Here we analysed trends in
age-specific cardiovascular mortality rates, and its major
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subtypes—ischaemic heart disease and cerebrovascular
disease—in the Netherlands between 1980 and 2009.
Methods
Data
National mortality rates were obtained for 10 year age
groups from age 35 to 84 years between 1980 and 2009 for
all circulatory disease (ICD-9 codes 390-459 & ICD-10
codes I00-I99), ischaemic heart disease (ICD-9 codes
410-414 & ICD-10 I20-I25) and cerebrovascular disease
(ICD-9 codes 430-438 & ICD-10 codes I60-I69). Numbers
of deaths and population counts (source: CBS Statline)
were used to calculate annual mortality rates.
A joinpoint Poisson regression provided the estimated
annual percentage change and detected points in time at
which significant changes in the trends occurred (Joinpoint
Regression Program, Version 3.4.2. October 2009; Statis-
tical Research and Applications Branch, National Cancer
Institute). The joinpoint permutation test was used to select
the most parsimonious model that best fitted the data.
A maximum of three joinpoints was allowed for estima-
tions. For each annual percentage change estimate, the
corresponding 95% confidence interval (95% CI) was
calculated [5].
A secondary analysis was also performed for compari-
son, using Poisson regression to analyse the annual rate of
change within each 5 year period between 1980 and 2009.
Results
The age-standardised rate of all circulatory disease mor-
tality has declined since 1980 in the Netherlands (Fig. 1),
from 357 per 100,000 to 130 per 100,000 in 2009 for males
and from 202 per 100,000 to 89 per 100,000 in 2009 for
females. Large decreases in ischaemic heart disease and
cerebrovascular disease mortality rates were observed for
all age groups between 1980 and 2009 (Fig. 2).
All circulatory disease mortality rates declined between
1980 and 2009 for all age and sex groups, with the rate of
decline accelerating over time in all groups (data not
shown).
Joinpoint analysis of ischaemic heart disease mortality
rates demonstrated similar trends (Table 1a). For males and
females in all age groups, an acceleration in the mortality
rate decline has been observed since the late 1990s/early
2000s. For some groups this represents a continually
increasing improvement in the mortality rates since 1980
(males 35–44, 55–64, 65–74, and 75–85, and females
45–54, 55–64, 65–74 and 75–84). For males aged 45–54
and females aged 35–44 this acceleration follows a period
of slowing of improvements in the mortality rate decline in
the 1990s.
Joinpoint analysis of cerebrovascular disease mortality
rates demonstrated improvements in mortality rates in the
most recent time period in all age and sex groups exam-
ined, following a slowing in the rate of decline in the late
1980s/early 1990s for males aged 45–54 and 65–74 and
females aged 45–54, 65–74 and 75–84 (Table 1b).
Analyses were also performed of mortality rates within
consecutive 5 year periods, and using 5-year age groups
(data not shown). The conclusions were unchanged—with
all analyses demonstrating a greater rate of mortality
improvement in the most recent period analysed.
Discussion
This detailed analysis of cardiovascular mortality rates
between 1980 and 2009 demonstrates that in the Nether-
lands all age and sex groups have experienced improve-
ments in all circulatory disease, IHD and cerebrovascular
mortality in recent times. There was no evidence of a
slowing in the IHD mortality rate decline for those aged
under 55 years.
Whilst the quality of the mortality data collection in
countries such as the Netherlands is generally high, coding
of death certificates has some problems, due primarily to
the number of ill-defined cardiovascular codes. This can
mean that comparisons between countries, and over time,
may not be counting the same causes of death as different
practitioners may assign the same cause of death to dif-
ferent codes. This is particularly important at older ages,
Fig. 1 Age-standardised all circulatory disease mortality rates
(standardised to the World Health Organisation World Standard).
Crosses represent males and circles represent females
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but less likely at younger ages. An analysis of this phe-
nomenon by the World Health Organisation suggested that
miscoding was minimal in the Netherlands [6]. In addition,
our analyses of all circulatory disease mortality demon-
strated the same broad trends as those for IHD and cere-
brovascular disease. Another potential cause of coding
inaccuracies is the change from ICD-9 to ICD-10. How-
ever, an analysis of coding discontinuities demonstrated no
significant discontinuities for this transition for the major
circulatory disease sub-types in the Netherlands [7]. Whilst
some of the apparent changes in trends may be due to
artefact, this is unlikely to affect the general conclusion
that for all age and sex groups, all circulatory disease, IHD
and cerebrovascular disease mortality rates are continuing
to decline in the Netherlands.
In almost all age and sex groups the rate of decline in
IHD mortality accelerated in the late 1990s to early 2000s.
This is consistent with what has been observed for age-
standardised mortality rates in a number of other countries,
including England, Wales and Scotland [3, 4] and the US
[2]. However, in contrast to the Netherlands, in England,
Wales, Scotland and the US the rate of decline in those aged
under 55 years of age slowed in the most recent period.
In the US the deceleration commenced in 1989, with
further deceleration observed in 2000 [2]. In England,
Wales and Scotland the decelerations commenced slightly
later, between 1994 and 2003 [3, 4]. Interestingly, in the
current analysis Dutch males aged 45–54 years also
experienced a deceleration in the IHD mortality rate
decline from 1993, but this was then followed by improved
mortality from 2000. Similarly, Dutch females aged 35–44
experienced an increase in the IHD mortality rate decline
from 1989, but this was then followed by improved mor-
tality from 1999.
It will be important to identify whether or not these
observed differences in trends between the Netherlands and
countries such as the US and UK represent a specific dif-
ference in the causes or treatment of circulatory disease.
The observed acceleration in the circulatory disease mor-
tality rate decline since the late 1990s may reflect broader
changes in the healthcare system in the Netherlands, as
since 2002 a general acceleration in all cause mortality, and
in particular mortality due to symptoms and ill-defined
conditions, has been observed [8, 9]. A recent analysis of
these trends suggests that this is due to general improve-
ments in health care services [9]. It will be important to
explore whether improvement of primary and secondary
prevention of CHD in countries such as the UK and US
would lead to the continued improvements in CHD mor-
tality in all adults observed in the Netherlands.
A B
C D
Fig. 2 Observed mortality rates in the Netherlands between 1980 and
2009 for each 10 year age group between 35 and 85 years (per
100,000, log scale). a Ischaemic heart disease mortality, males,
b Ischaemic heart disease mortality, females, c Cerebrovascular
disease mortality, males, d Cerebrovascular disease mortality,
females
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Alternatively, the current analysis may provide some
support for the hypothesis that the observed flattening of
the CHD mortality rate in those under age 55 in countries
such as the US and UK reflects increased prevalence of
obesity and diabetes [3, 10, 11]. The Netherlands has a
markedly lower prevalence of adult obesity than countries
such as the UK and US, has experienced lower absolute
increases in obesity over the past decade [12–14] and
consequently has a lower prevalence of diabetes in adults
[15]. It will be important to continue to monitor trends in
the Netherlands to see whether the mortality rate decline in
younger adults continues.
In conclusion, all circulatory, IHD and cerebrovascular
disease mortality rates are continuing to improve in the
Netherlands in all age and sex groups. This is in contrast to
trends in those aged under 55 years of age observed in an
increasing number of countries. It will be critical to con-
tinue to monitor these trends in the Netherlands, and to
elucidate the reason for their apparent divergence with
countries such as the US and the UK.
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